News – Page 118 – Endpoints News

Big employers are spending even more money on pharmacy costs, driven by GLP-1s and other high-cost therapies, survey ...

9 months ago

TCGX and JPM help Pathalys raise $105M to go up against Amgen in subset of kidney disease

9 months ago

J&J buys another medtech company, this time paying $600M upfront for Israel-based V-Wave

9 months ago

Merck rejigs ADC deal with Kelun, grabbing one program and returning another

9 months ago

Lilly says tirzepatide kept obese and overweight people from developing diabetes

9 months ago

Half of IRA negotiation savings to come from three drugs, Brookings finds

9 months ago

Pfizer brings Indian generics maker to court over Xeljanz patent

9 months ago

Liquidia scores only tentative approval for Yutrepia due to Tyvaso exclusivity

9 months ago

Walgreens nabs $100M BARDA partnership to expand decentralized clinical trials

9 months ago

BioNTech, MediLink to resume trial enrollment for HER3 antibody-drug conjugate after FDA pause

9 months ago

Avidity’s upsized $345M offering; Janus Henderson’s new $150M biotech fund

9 months ago

Q&A: Lilly’s top scientists on genetic medicine ambitions, and how they’re not just for rare diseases

9 months ago

TYK Medicines seeks to launch new EGFR drug in China with $74M Hong Kong IPO

9 months ago

Unpacking IRA price negotiations results; Lykos’ tough week; Genentech rethinks cancer immunology; and more

9 months ago

Medicare negotiations have concluded. What's next for court cases against the IRA?

9 months ago

FDA approves AstraZeneca’s Imfinzi before and after lung cancer surgery

9 months ago

Carbon Health CEO Eren Bali steps down

9 months ago

Avantor sells off CRO for $650M to private equity firm

9 months ago

Q&A: Lykos just cut 75% of its workforce after an FDA rejection. Here’s what the CEO has to say

9 months ago

AN2’s poison pill; Pfizer shares promising mid-stage data for flu shot

9 months ago

Novo Nordisk subsidiary to build $220M API facility for chronic disease drugs

9 months ago

Incyte plans label expansion for cancer drug Monjuvi following positive topline data

9 months ago

Pfizer, BioNTech review next steps as Covid and flu combo vaccine delivers mixed data

9 months ago

Esperion's CMO hits the exit; Pfizer appoints Nvidia alum as AI chief

9 months ago

First page Previous page 115 116 117118119 120 121 Next page Last page